Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities    
Net loss $ (2,141,464) $ (2,323,235)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 41,521 53,171
Amortization of debt discount 515,204 1,051,707
Change in fair value of derivative liability (19,000) (1,116,500)
Change in fair value of warrant liability 0 47,000
Financing costs related to convertible debentures 0 1,361,735
Default penalty 27,000 0
Net loss attributable to non-controlling interest (51,363) 0
Shares issued for services 0 0
Changes in operating assets and liabilities:    
Inventory 0 (4,200)
Prepaid expenses and other current assets (91,643) (543)
Deposits (10,133) 0
Accounts payable 56,002 (1,403)
Other accrued expenses 180,728 103,732
Accrued interest - related parties (10,560) 145,641
Cash used in operating activities (1,503,708) (682,895)
Cash flows from investing activities    
Cash paid for machinery and equipment (611,790) (5,350)
Cash paid for construction in progress (541,735) (75,404)
Cash used in investing activitites (1,153,525) (80,754)
Cash flows from financing activities    
Payments on bank loan (5,989) (5,689)
Repayment line of credit short-term (110,788) (3,153)
Notes receivable 0 150,000
Proceeds from sale of stock 1,774,001 179,916
Proceeds from sale of Series B Convertible Preferred stock 1,500,000 0
Proceeds from convertible debentures 100,000 565,800
Payments on convertible debentures (85,500) (123,037)
Payments on convertible debentures, related party (69,000) 0
Cash provided by financing activities 3,102,724 763,837
NET CHANGE IN CASH 445,491 188
CASH AT BEGINNING OF PERIOD 137,499 24,280
CASH AT END OF PERIOD 582,990 24,468
INTEREST PAID 170,911 96,018
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Shares issued upon conversion 383,448 1,128,068
Shares issued upon exercise of warrants 0 150,000
Right of use asset and lease liability 275,400 0
Notes receivable for convertible debentures 0 90,000
Conversion of common shares to Series A Preferred Shares $ 0 $ 500